Pharmacogenomics testing for cancer patients can help identify genetic anomalies affecting drug metabolism and alert pharmacists about the need to evaluate therapy options for pain and supportive care, Mayo Clinic researchers reported.
In a pharmacogenomics study that assessed factors including patients’ genotypes and drug–drug–gene interactions, the majority of the 200 patients tested were found to metabolize in a way that could affect their processing of certain